Arena Faces New FDA Worries Over Weight-Loss Drug
U.S. Food and Drug Administration drug reviewers said Tuesday that Arena Pharmaceuticals had eased concerns about potential cancer risks associated with its obesity drug lorcaserin, but said a high risk of...To view the full article, register now.
Already a subscriber? Click here to view full article